SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals
Peter V. Coyle, View ORCID ProfileHiam Chemaitelly, Mohamed Ali Ben Hadj Kacem, Naema Hassan Abdulla Al Molawi, Reham Awni El Kahlout, Imtiaz Gilliani, Nourah Younes, Zaina Al Kanaani, Abdullatif Al Khal, Einas Al Kuwari, Adeel A. Butt, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Riyazuddin Mohammad Shaik, Hanan F. Abdul Rahim, Gheyath K. Nasrallah, Hadi M. Yassine, Mohamed G. Al Kuwari, Hamad Eid Al Romaihi, Mohamed H. Al-Thani, Roberto Bertollini, View ORCID ProfileLaith J. Abu-Raddad
doi: https://doi.org/10.1101/2021.01.05.21249247
Peter V. Coyle
1Hamad Medical Corporation, Doha, Qatar
Hiam Chemaitelly
2Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
3World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine–Qatar, Cornell University, Qatar Foundation – Education City, Doha, Qatar
Mohamed Ali Ben Hadj Kacem
1Hamad Medical Corporation, Doha, Qatar
Naema Hassan Abdulla Al Molawi
1Hamad Medical Corporation, Doha, Qatar
Reham Awni El Kahlout
1Hamad Medical Corporation, Doha, Qatar
Imtiaz Gilliani
1Hamad Medical Corporation, Doha, Qatar
Nourah Younes
1Hamad Medical Corporation, Doha, Qatar
Zaina Al Kanaani
1Hamad Medical Corporation, Doha, Qatar
Abdullatif Al Khal
1Hamad Medical Corporation, Doha, Qatar
Einas Al Kuwari
1Hamad Medical Corporation, Doha, Qatar
Adeel A. Butt
1Hamad Medical Corporation, Doha, Qatar
9Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, New York, USA
Andrew Jeremijenko
1Hamad Medical Corporation, Doha, Qatar
Anvar Hassan Kaleeckal
1Hamad Medical Corporation, Doha, Qatar
Ali Nizar Latif
1Hamad Medical Corporation, Doha, Qatar
Riyazuddin Mohammad Shaik
1Hamad Medical Corporation, Doha, Qatar
Hanan F. Abdul Rahim
4College of Health Sciences, QU Health, Qatar University, Doha, Qatar
Gheyath K. Nasrallah
5Biomedical Research Center, Qatar University, Doha, Qatar
6Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar
Hadi M. Yassine
5Biomedical Research Center, Qatar University, Doha, Qatar
6Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar
Mohamed G. Al Kuwari
7Primary Health Care Corporation, Doha, Qatar
Hamad Eid Al Romaihi
8Ministry of Public Health, Doha, Qatar
Mohamed H. Al-Thani
8Ministry of Public Health, Doha, Qatar
Roberto Bertollini
8Ministry of Public Health, Doha, Qatar
Laith J. Abu-Raddad
2Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar
3World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine–Qatar, Cornell University, Qatar Foundation – Education City, Doha, Qatar
9Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, New York, USA
Data Availability
All data are available within the manuscript and its supplementary materials.
Posted January 06, 2021.
SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals
Peter V. Coyle, Hiam Chemaitelly, Mohamed Ali Ben Hadj Kacem, Naema Hassan Abdulla Al Molawi, Reham Awni El Kahlout, Imtiaz Gilliani, Nourah Younes, Zaina Al Kanaani, Abdullatif Al Khal, Einas Al Kuwari, Adeel A. Butt, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Riyazuddin Mohammad Shaik, Hanan F. Abdul Rahim, Gheyath K. Nasrallah, Hadi M. Yassine, Mohamed G. Al Kuwari, Hamad Eid Al Romaihi, Mohamed H. Al-Thani, Roberto Bertollini, Laith J. Abu-Raddad
medRxiv 2021.01.05.21249247; doi: https://doi.org/10.1101/2021.01.05.21249247
SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals
Peter V. Coyle, Hiam Chemaitelly, Mohamed Ali Ben Hadj Kacem, Naema Hassan Abdulla Al Molawi, Reham Awni El Kahlout, Imtiaz Gilliani, Nourah Younes, Zaina Al Kanaani, Abdullatif Al Khal, Einas Al Kuwari, Adeel A. Butt, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Riyazuddin Mohammad Shaik, Hanan F. Abdul Rahim, Gheyath K. Nasrallah, Hadi M. Yassine, Mohamed G. Al Kuwari, Hamad Eid Al Romaihi, Mohamed H. Al-Thani, Roberto Bertollini, Laith J. Abu-Raddad
medRxiv 2021.01.05.21249247; doi: https://doi.org/10.1101/2021.01.05.21249247
Subject Area
Subject Areas
- Addiction Medicine (401)
- Allergy and Immunology (711)
- Anesthesia (204)
- Cardiovascular Medicine (2964)
- Dermatology (250)
- Emergency Medicine (443)
- Epidemiology (12774)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4605)
- Geriatric Medicine (422)
- Health Economics (732)
- Health Informatics (2938)
- Health Policy (1070)
- Hematology (390)
- HIV/AIDS (927)
- Medical Education (429)
- Medical Ethics (116)
- Nephrology (474)
- Neurology (4386)
- Nursing (237)
- Nutrition (643)
- Oncology (2282)
- Ophthalmology (649)
- Orthopedics (258)
- Otolaryngology (326)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1199)
- Primary Care Research (499)
- Public and Global Health (6973)
- Radiology and Imaging (1538)
- Respiratory Medicine (917)
- Rheumatology (442)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)